person · Reporting owner

Bujarski Robert Joseph

Disclosed activity across 2 companies

Tapewire entity: 86707
SEC CIK: 0001333458

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
QuidelOrtho CorpQDEL · Entity 4986	EVP & COO	October 15, 2024	October 17, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

QuidelOrtho Corp

Report date October 15, 2024 · Filed October 17, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	44,810	Ending reported balance After 2024-10-15 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2024-10-15 · Grant · Acquired 390 · Balance 45,027 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2024-10-15 · Tax withholding · Disposed 217 · Balance 44,810 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	390	Reported balance After 2024-10-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-10-15 · Exercise / conversion · Disposed 390 · Balance 390 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects release of restricted stock units that were previously reported on a Form 4.

F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

F4: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

QUIDEL CORP /DE/

Report date May 27, 2022 · Filed June 01, 2022

Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2022-05-27 transaction · row 1 1 source row Row 1 · 2022-05-27 · Disposition to issuer · Disposed 29,164 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $23.41 · Expires 2025-02-05	Direct	Reported balance After 2022-05-27 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-05-27 · Disposition to issuer · Disposed 8,798 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $15.40 · Expires 2026-02-10	Direct	Reported balance After 2022-05-27 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-05-27 · Disposition to issuer · Disposed 17,596 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $21.08 · Expires 2027-02-15	Direct	Reported balance After 2022-05-27 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2022-05-27 · Disposition to issuer · Disposed 14,343 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $46.41 · Expires 2028-01-16	Direct	Reported balance After 2022-05-27 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2022-05-27 · Disposition to issuer · Disposed 9,212 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $59.12 · Expires 2029-02-04	Direct	Reported balance After 2022-05-27 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2022-05-27 · Disposition to issuer · Disposed 7,246 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $77.16 · Expires 2030-02-03	Direct	Reported balance After 2022-05-27 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2022-05-27 · Disposition to issuer · Disposed 6,641 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $159.39 · Expires 2030-09-14	Direct	Reported balance After 2022-05-27 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-05-27 · Disposition to issuer · Disposed 2,935 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F6: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $254.00 · Expires 2031-02-01	Direct	Reported balance After 2022-05-27 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-05-27 · Disposition to issuer · Disposed 3,514 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $103.36 · Expires 2032-01-31	Direct	Reported balance After 2022-05-27 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-05-27 · Disposition to issuer · Disposed 12,876 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2022-05-27 · Disposition to issuer · Disposed 3,623 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 3,623 shares will vest on February 4, 2023.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2022-05-27 · Disposition to issuer · Disposed 2,749 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2022-05-27 · Disposition to issuer · Disposed 824 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2022-05-27 · Disposition to issuer · Disposed 1,033 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,033 shares will vest on November 18, 2022.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2022-05-27 · Disposition to issuer · Disposed 3,320 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2022-05-27 · Disposition to issuer · Disposed 1,052 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2022-05-27 · Disposition to issuer · Disposed 315 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2022-05-27 · Disposition to issuer · Disposed 941 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2022-05-27 · Disposition to issuer · Disposed 1,351 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2022-05-27 · Disposition to issuer · Disposed 405 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · 2022-05-27 · Disposition to issuer · Disposed 2,637 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · 2022-05-27 · Disposition to issuer · Disposed 1,559 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F17: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 23 Instrument identity requires review; Table II rows are not merged. 1 source row Row 23 · 2022-05-27 · Disposition to issuer · Disposed 12,878 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F18: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 24 Instrument identity requires review; Table II rows are not merged. 1 source row Row 24 · 2022-05-27 · Disposition to issuer · Disposed 13,545 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F19: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 25 Instrument identity requires review; Table II rows are not merged. 1 source row Row 25 · 2022-05-27 · Disposition to issuer · Disposed 1,190 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 26 Instrument identity requires review; Table II rows are not merged. 1 source row Row 26 · 2022-05-27 · Disposition to issuer · Disposed 357 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F20: 357 shares will vest on January 31, 2023.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.

F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3: Vested in full.

F4: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023.

F5: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

F6: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024.

F7: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025.

F8: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026.

F9: Each restricted stock unit represents the right to receive one share of Quidel common stock.

F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F11: 3,623 shares will vest on February 4, 2023.

F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F13: 1,033 shares will vest on November 18, 2022.

F14: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

F15: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.

F16: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.

F17: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.

F18: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.

F19: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.

F20: 357 shares will vest on January 31, 2023.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 24, 2018 Filed Feb 27, 2018 20:27 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	113	$43.95	$4,966.35	Disclosure SEC source: 0001209191-18-014296 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,938 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 24, 2018 Filed Feb 27, 2018 20:27 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	327	$0.00	$0.00	Disclosure SEC source: 0001209191-18-014296 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,051 F1 · shares: Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:38 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	2,479	$45.10	$111,802.90	Disclosure SEC source: 0001209191-18-011713 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,724 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:38 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	7,171	$0.00	$0.00	Disclosure SEC source: 0001209191-18-011713 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,203 F1 · shares: Reporting Person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 2/15/2017. Read SEC document
February 10, 2018 Filed Feb 13, 2018 20:10 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	841	$42.94	$36,112.54	Disclosure SEC source: 0001209191-18-009820 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,032 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 10, 2018 Filed Feb 13, 2018 20:10 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	2,403	$0.00	$0.00	Disclosure SEC source: 0001209191-18-009820 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,873 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:16 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	490	$43.58	$21,354.20	Disclosure SEC source: 0001209191-18-008280 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,470 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 05, 2018 Filed Feb 7, 2018 20:16 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,201	$0.00	$0.00	Disclosure SEC source: 0001209191-18-008280 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,960 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
January 16, 2018 Filed Jan 23, 2018 17:27 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	4,606	$0.00	$0.00	Disclosure SEC source: 0001209191-18-004955 · doc4.xml · derivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,606 Underlying: Common Stock · 4,606 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F3 · derivative.exercise_date: 4,606 shares will vest on the fourth anniversary date of the grant date, January 16, 2022. F3 · derivative.expiration_date: 4,606 shares will vest on the fourth anniversary date of the grant date, January 16, 2022. Read SEC document
January 16, 2018 Filed Jan 23, 2018 17:27 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantNon-Qualified Stock Option · Derivative	9,212	$0.00 Strike: $46.41	$0.00	Disclosure SEC source: 0001209191-18-004955 · doc4.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,212 Underlying: Common Stock · 9,212 shares Expires 2028-01-16 F1 · derivative.exercise_date: 4,606 shares will vest on the second anniversary date of the grant date, January 16, 2020. 2,303 shares will vest on the third anniversary date of the grant date, January 16, 2021. 2,303 shares will vest on the fourth anniversary date of the grant date, January 16, 2022. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Option · Derivative	17,596	$0.00 Strike: $23.41	$0.00	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · derivative · entry 13 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,596 Underlying: Common Stock · 17,596 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: 17,596 shares vested on 02/05/2017. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Option · Derivative	21,465	$0.00 Strike: $27.57	$0.00	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · derivative · entry 12 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,156 Underlying: Common Stock · 21,465 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 14,310 shares vested on 02/24/2016; and 7,155 shares vested on 02/24/2017. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Option · Derivative	29,605	$0.00 Strike: $22.21	$0.00	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · derivative · entry 11 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,605 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 14,803 shares vested on 02/25/2015; 7,401 shares vested on 02/25/2016; and 7,401 shares vested on 02/25/2017. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Option · Derivative	42,038	$0.00 Strike: $15.19	$0.00	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · derivative · entry 10 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,038 shares Expires 2022-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 21,019 shares vested on 03/02/2014; 10,509 shares vested on 03/02/2015; and 10,510 shares vested on 03/02/2016. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	28,666	$40.01	$1,146,998.33	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · nonDerivative · entry 9 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,759 F5 · price: The weighted average sale price for these transactions was $40.0125 per share, with a range of $40.00 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	20,000	$39.70	$794,098.00	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · nonDerivative · entry 8 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,425 F4 · price: The weighted average sale price for these transactions was $39.7049 per share, with a range of $39.50 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	20,000	$39.69	$793,796.00	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · nonDerivative · entry 7 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,425 F3 · price: The weighted average sale price for these transactions was $39.6898 per share, with a range of $39.20 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	20,000	$39.69	$793,716.00	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · nonDerivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,425 F2 · price: The weighted average sale price for these transactions was $39.6898 per share, with a range of $39.20 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	22,038	$39.69	$874,681.61	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · nonDerivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,425 F1 · price: The weighted average sale price for these transactions was $39.6897 per share, with a range of $39.21 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	17,596	$23.41	$411,922.36	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	21,465	$27.57	$591,790.05	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	29,605	$22.21	$657,527.05	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 15, 2017 Filed Dec 15, 2017 19:30 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	42,038	$15.19	$638,557.22	Disclosure SEC source: 0001209191-17-066064 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 02, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Options · Derivative	10,000	$0.00 Strike: $12.63	$0.00	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · derivative · entry 10 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 02, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	10,000	$24.50	$245,000.00	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · nonDerivative · entry 7 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,759 Read SEC document
May 02, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	10,000	$12.63	$126,300.00	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · nonDerivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 01, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Options · Derivative	20,000	$0.00 Strike: $12.63	$0.00	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · derivative · entry 9 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 20,000 shares Expires 2021-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 01, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Options · Derivative	6,225	$0.00 Strike: $15.28	$0.00	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · derivative · entry 8 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,225 shares Expires 2020-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 01, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	20,000	$24.20	$483,978.00	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · nonDerivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,759 F2 · price: The weighted average sale price for these transactions was $24.1989 per share, with a range of $24.03 to $24.38 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
May 01, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	20,000	$12.63	$252,600.00	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 01, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	7,000	$24.19	$169,360.10	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,759 F1 · price: The weighted average sale price for these transactions was $24.1943 per share, with a range of $23.995 to $24.42 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
May 01, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	6,225	$24.19	$150,609.52	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,759 F1 · price: The weighted average sale price for these transactions was $24.1943 per share, with a range of $23.995 to $24.42 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
May 01, 2017 Filed May 3, 2017 20:18 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	6,225	$15.28	$95,118.00	Disclosure SEC source: 0001209191-17-029842 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 01, 2017 Filed Mar 3, 2017 20:06 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	206	$21.96	$4,523.76	Disclosure SEC source: 0001209191-17-018076 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,759 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
March 01, 2017 Filed Mar 3, 2017 20:06 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	486	$0.00	$0.00	Disclosure SEC source: 0001209191-17-018076 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,965 F1 · shares: Reflects release of restricted stock units that were previously reported on Form 4. Read SEC document
March 01, 2017 Filed Mar 3, 2017 20:06 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	651	$21.96	$14,295.96	Disclosure SEC source: 0001209191-17-018076 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,479 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
March 01, 2017 Filed Mar 3, 2017 20:06 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,620	$0.00	$0.00	Disclosure SEC source: 0001209191-17-018076 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,130 F1 · shares: Reflects release of restricted stock units that were previously reported on Form 4. Read SEC document
February 25, 2017 Filed Feb 28, 2017 20:47 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	143	$21.15	$3,024.45	Disclosure SEC source: 0001209191-17-015560 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,510 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 25, 2017 Filed Feb 28, 2017 20:47 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	338	$0.00	$0.00	Disclosure SEC source: 0001209191-17-015560 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,653 F1 · shares: Reflects release of restricted stock units that were previously reported on Form 4. Read SEC document
February 24, 2017 Filed Feb 28, 2017 20:47 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	138	$21.15	$2,918.70	Disclosure SEC source: 0001209191-17-015560 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,315 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 24, 2017 Filed Feb 28, 2017 20:47 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	326	$0.00	$0.00	Disclosure SEC source: 0001209191-17-015560 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,453 F1 · shares: Reflects release of restricted stock units that were previously reported on Form 4. Read SEC document
February 17, 2017 Filed Feb 17, 2017 20:54 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Premium) · Derivative	1,094	$0.00	$0.00	Disclosure SEC source: 0001209191-17-012416 · doc4.xml · derivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,094 Underlying: Common Stock · 1,094 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F6 · derivative.exercise_date: The restricted stock units vest on the first anniversary date of the grant date, February 17, 2018. F6 · derivative.expiration_date: The restricted stock units vest on the first anniversary date of the grant date, February 17, 2018. Read SEC document
February 17, 2017 Filed Feb 17, 2017 20:54 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Converted) · Derivative	3,646	$0.00	$0.00	Disclosure SEC source: 0001209191-17-012416 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,646 Underlying: Common Stock · 3,646 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest on the date of grant, February 17, 2017. F5 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting persons 2016 cash bonus pursuant to the 2016 Employee Deferred Bonus Compensation Plan. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:54 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	7,172	$0.00	$0.00	Disclosure SEC source: 0001209191-17-012416 · doc4.xml · derivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,172 Underlying: Common Stock · 7,172 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F3 · derivative.exercise_date: 7,172 shares will vest on the fourth anniversary date of the grant date, February 15, 2021. F3 · derivative.expiration_date: 7,172 shares will vest on the fourth anniversary date of the grant date, February 15, 2021. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:54 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantNon-Qualified Stock Options · Derivative	14,343	$0.00 Strike: $21.08	$0.00	Disclosure SEC source: 0001209191-17-012416 · doc4.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,343 Underlying: Common Stock · 14,343 shares Expires 2027-02-15 F1 · derivative.exercise_date: 7,172 shares will vest on the second anniversary date of the grant date, February 15, 2019. 3,586 shares will vest on the third anniversary date of the grant date, February 15, 2020. 3,585 shares will vest on the fourth anniversary date of the grant date, February 15, 2021. Read SEC document
February 05, 2017 Filed Feb 8, 2017 21:07 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	1,172	$19.15	$22,443.80	Disclosure SEC source: 0001209191-17-008948 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,127 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 05, 2017 Filed Feb 8, 2017 21:07 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	2,403	$0.00	$0.00	Disclosure SEC source: 0001209191-17-008948 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,299 F1 · shares: Reflects release of restricted stock units that were previously reported on Form 4. Read SEC document
December 01, 2016 Filed Dec 2, 2016 19:40 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Options · Derivative	2,712	$0.00 Strike: $15.28	$0.00	Disclosure SEC source: 0001209191-16-153182 · doc4.xml · derivative · entry 18 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,225 Underlying: Common Stock · 2,712 shares Expires 2020-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 01, 2016 Filed Dec 2, 2016 19:40 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	2,712	$23.00	$62,376.00	Disclosure SEC source: 0001209191-16-153182 · doc4.xml · nonDerivative · entry 13 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,896 Read SEC document
December 01, 2016 Filed Dec 2, 2016 19:40 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	2,712	$15.28	$41,439.36	Disclosure SEC source: 0001209191-16-153182 · doc4.xml · nonDerivative · entry 12 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.